Provided by Tiger Fintech (Singapore) Pte. Ltd.

Soleno Therapeutics

68.69
-1.5600-2.22%
Volume:94.00K
Turnover:6.57M
Market Cap:3.15B
PE:-15.69
High:71.00
Open:69.85
Low:68.65
Close:70.25
Loading ...

BRIEF-Soleno Therapeutics Inc - FDA Approves Soleno's Vykat XR For Hyperphagia In Prader-Willi Syndrome - SEC Filing

Reuters
·
27 Mar

Soleno Therapeutics Inc - FDA Approves Soleno's Vykat Xr for Hyperphagia in Prader-Willi Syndrome - SEC Filing

THOMSON REUTERS
·
27 Mar

Soleno Therapeutics trading halted, news pending

TIPRANKS
·
27 Mar

BUZZ-Stifel resumes Soleno coverage with 'buy' rating, citing potential of rare disease drug

Reuters
·
06 Mar

Stock Track | Soleno Therapeutics Plummets 5.07% Amid Disappointing Q4 Earnings Miss

Stock Track
·
05 Mar

Soleno Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
04 Mar

Exploring US High Growth Tech Stocks In March 2025

Simply Wall St.
·
04 Mar

Soleno Therapeutics Price Target Maintained With a $70.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Mar

Optimistic Buy Rating for Soleno Therapeutics Amid Anticipated FDA Approval and Strong Financial Position

TIPRANKS
·
03 Mar

Soleno Therapeutics Reports 2024 Financial Results and Strategic Progress

TIPRANKS
·
01 Mar

Soleno Therapeutics Q4 2024 GAAP EPS $(1.27) Misses $(0.94) Estimate

Benzinga
·
28 Feb

Soleno Therapeutics Q4 Basic EPS USD -1.27

THOMSON REUTERS
·
28 Feb

Soleno Therapeutics Q4 Operating Expenses USD 59.116 Million

THOMSON REUTERS
·
28 Feb

Soleno Therapeutics to Participate in Upcoming February Investor Conferences

GlobeNewswire
·
30 Jan

Soleno Therapeutics Enhances Executive Compensation Structure

TIPRANKS
·
25 Jan

BRIEF-Soleno Therapeutics Enters Into $200 Million Debt Financing With Oxford Finance Llc

Reuters
·
18 Dec 2024

Soleno Therapeutics Gets $200 Million Debt Financing From Oxford Finance

MT Newswires Live
·
18 Dec 2024

Soleno Therapeutics Enters Into $200 Million Debt Financing With Oxford Finance Llc

THOMSON REUTERS
·
18 Dec 2024

Press Release: Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC

Dow Jones
·
18 Dec 2024

Soleno Therapeutics Price Target Maintained With a $70.00/Share by HC Wainwright & Co.

Dow Jones
·
02 Dec 2024